Citation Impact
Citing Papers
Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations
2011
EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib
2012
Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non–Small Cell Lung Cancer
2013
Resistance to BRAF Inhibition in BRAF-Mutant Colon Cancer Can Be Overcome with PI3K Inhibition or Demethylating Agents
2012
Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment
2018 StandoutNobel
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Bifluoride Ion Mediated SuFEx Trifluoromethylation of Sulfonyl Fluorides and Iminosulfur Oxydifluorides
2019 StandoutNobel
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
2019 Standout
B-Raf and the inhibitors: from bench to bedside
2013
Idiopathic pulmonary fibrosis
2017 Standout
Src kinases involved in hepatitis B virus replication
1999
WISP1 Predicts Clinical Prognosis and Is Associated With Tumor Purity, Immunocyte Infiltration, and Macrophage M2 Polarization in Pan-Cancer
2020
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Inhibition of autophagy with chloroquine is effective in melanoma
2013
MEK in cancer and cancer therapy
2013
A view on drug resistance in cancer
2019 StandoutNature
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
2009
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
2006 Standout
Tumor adaptation and resistance to RAF inhibitors
2013
Hepatitis B Virus X Protein Inhibits Transforming Growth Factor-β-induced Apoptosis through the Activation of Phosphatidylinositol 3-Kinase Pathway
2000
The biology and management of non-small cell lung cancer
2018 StandoutNature
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
2014 StandoutNature
Imaging in the era of molecular oncology
2008 StandoutNature
Cancer drug resistance: an evolving paradigm
2013 Standout
Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma
2005
Colorectal cancer
2013 Standout
Integrating single-cell transcriptomic data across different conditions, technologies, and species
2018 Standout
Decision making by p53: life, death and cancer
2003
Influenza Virus-induced NF-κB-dependent Gene Expression Is Mediated by Overexpression of Viral Proteins and Involves Oxidative Radicals and Activation of IκB Kinase
2000
Targeting Mutant BRAF in Melanoma
2012
Lung cancer: current therapies and new targeted treatments
2016 Standout
Hepatitis B virus X protein induces apoptosis in hepatoma cells through inhibiting Bcl-xL expression
2005
The single-cell transcriptional landscape of mammalian organogenesis
2019 StandoutNature
Cancer genes and the pathways they control
2004 Standout
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
NF-κB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival
2002
Wnt/β-Catenin Signaling and Disease
2012 Standout
Enrichr: a comprehensive gene set enrichment analysis web server 2016 update
2016 Standout
Liver-specific Enhancer II Is the Target for the p53-mediated Inhibition of Hepatitis B Viral Gene Expression
1998
Moving in the right direction—Nanoimaging in cancer cell motility and metastasis
2007
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
2015 Standout
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Live or let die: the cell's response to p53
2002 Standout
NF-κB regulation in the immune system
2002 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Targeted therapy in metastatic colorectal cancer – An example of personalised medicine in action
2013
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
PTEN Deletion and Concomitant c-Myc Activation Do Not Lead to Tumor Formation in Pancreatic β Cells
2008 StandoutNobel
Reactive oxygen species have a causal role in multiple forms of insulin resistance
2006 StandoutNature
Hepatitis B virus X protein: a multifunctional viral regulator
2001
The biogenesis, biology and characterization of circular RNAs
2019 Standout
Oncogenic DNA viruses
2001 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Idiopathic pulmonary fibrosis
2011 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin
2005
Association of the Gene Encoding Wingless-Type Mammary Tumor Virus Integration-Site Family Member 5B (WNT5B) with Type 2 Diabetes
2004
Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial
2012
Glucocorticoids Inhibit the Transcriptional Activity of LEF/TCF in Differentiating Osteoblasts in a Glycogen Synthase Kinase-3β-dependent and -independent Manner
2004
Pro-angiogenic Activities of CYR61 (CCN1) Mediated through Integrins αvβ3 and α6β1 in Human Umbilical Vein Endothelial Cells
2002 Standout
Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma
2013
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
Targeting T cell metabolism for therapy
2015
Tumor Necrosis Factor Inhibits Spread of Hepatitis C Virus Among Liver Cells, Independent From Interferons
2017 StandoutNobel
Gene Expression Profiles Distinguish Idiopathic Pulmonary Fibrosis from Hypersensitivity Pneumonitis
2005
Monofluorination of Organic Compounds: 10 Years of Innovation
2015 Standout
3d Transition Metals for C–H Activation
2018 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
NF-κB Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions
2002 Standout
Hepatitis B virus and hepatocellular carcinoma
2001
The Oncogenic BRAF Kinase Inhibitor PLX4032/RG7204 Does Not Affect the Viability or Function of Human Lymphocytes across a Wide Range of Concentrations
2010
Cyclin-dependent kinases regulate lysosomal degradation of hypoxia-inducible factor 1α to promote cell-cycle progression
2014 StandoutNobel
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Phosphaplatins, next generation platinum antitumor agents: A paradigm shift in designing and defining molecular targets
2012
Tumor Necrosis Factor Alpha Inhibition of Hepatitis B Virus Replication Involves Disruption of Capsid Integrity through Activation of NF-κB
2003
RMP, a Novel RNA Polymerase II Subunit 5-Interacting Protein, Counteracts Transactivation by Hepatitis B Virus X Protein
1998
g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)
2019 Standout
Hepatitis C Virus Core Protein Enhances NF-κB Signal Pathway Triggering by Lymphotoxin-β Receptor Ligand and Tumor Necrosis Factor Alpha
1999
Metabolic reprogramming and cancer progression
2020 StandoutScience
CYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity
2002
Activation of Src Family Kinases by Hepatitis B Virus HBx Protein and Coupled Signaling to Ras
1997
Cancer Genome Landscapes
2013 StandoutScience
HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53
2003 StandoutNobel
Architecture of RNA Polymerase II and Implications for the Transcription Mechanism
2000 StandoutScienceNobel
CF2H, a Hydrogen Bond Donor
2017 Standout
Works of Fei Su being referenced
RG7204 (PLX4032), a Selective BRAFV600E Inhibitor, Displays Potent Antitumor Activity in Preclinical Melanoma Models
2010
Antitumor Activity of BRAF Inhibitor Vemurafenib in Preclinical Models of BRAF-Mutant Colorectal Cancer
2011
Adjuvant effect of docetaxel on the immune responses to influenza A H1N1 vaccine in mice
2012
FDG-PET is a good biomarker of both early response and acquired resistance in BRAFV600 mutant melanomas treated with vemurafenib and the MEK inhibitor GDC-0973
2012
ESEA: Discovering the Dysregulated Pathways based on Edge Set Enrichment Analysis
2015
Overexpression of WISP-1 Down-regulated Motility and Invasion of Lung Cancer Cells through Inhibition of Rac Activation
2003
WISP-1 attenuates p53-mediated apoptosis in response to DNA damage through activation of the Akt kinase
2002
Screening of circular RNAs and validation of circANKRD36 associated with inflammation in patients with type 2 diabetes mellitus
2018
Hepatitis B virus HBx protein activates transcription factor NF-kappaB by acting on multiple cytoplasmic inhibitors of rel-related proteins
1996